Virtu Financial LLC Oncocyte Corp Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.2 - $0.35 $13,024 - $22,793	65,123 New	65,123 $15,000
Q3 2022 Nov 07, 2022	SELL	$0.76 - $15.98 $7,739 - $162,724	-10,183 Reduced 49.1%	10,558 $8,000
Q2 2022 Aug 09, 2022	BUY	$0.86 - $1.53 $17,837 - $31,733	20,741 New	20,741 $19,000
Q1 2021 May 19, 2021	SELL	$2.39 - $6.5 $88,501 - $240,695	-37,030 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.38 - $2.63 $51,101 - $97,388	37,030 New	37,030 $89,000
Q3 2020 Dec 11, 2020	SELL	$1.2 - $1.89 $31,804 - $50,092	-26,504 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$1.91 - $3.45 $7,072 - $12,775	3,703 Added 16.24%	26,504 $51,000
Q4 2019 Feb 04, 2020	BUY	$1.51 - $2.27 $34,429 - $51,758	22,801 New	22,801 $51,000
Q2 2019 Aug 13, 2019	SELL	$2.49 - $5.45 $71,918 - $157,412	-28,883 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.47 - $5.91 $42,458 - $170,698	28,883 New	28,883 $114,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.